Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Control of T cell activation by vitamin D.
Safety Study of Combination Therapy with Intramuscular Avonex and Oral CellCept in Patients with Multiple Sclerosis
Acute pure motor demyelinating neuropathy with hyperreflexia and anti-GalNAc-GD1a antibodies.
Axonal activity-dependent myelination in development: Insights for myelin repair.
Developmental changes in plasticity, synaptic, glia and connectivity protein levels in rat dorsal hippocampus.
Lymphopenia in treatment-naive relapsing multiple sclerosis.
Correction of Footdrop Due to Multiple Sclerosis Using the STIMuSTEP Implanted Dropped Foot Stimulator.
Vitamin D as a T-cell modulator in multiple sclerosis.
Biological therapy and neurological manifestations. What do we know?
Review of the novelties from the 31st ECTRIMS Congress, 2015, presented at the 8th Post-ECTRIMS meeting.
Liposomal nano-drugs based on amphipathic weak acid steroid prodrugs for treatment of inflammatory diseases.
Newly diagnosed ganglioglioma in an adult patient with multiple sclerosis.
Update on therapeutic options for multiple sclerosis.
Advanced intercross line mapping suggests that ncf1 (ean6) regulates severity in an animal model of guillain-barre syndrome.
Enhanced glucocorticoid receptor signaling in T cells impacts thymocyte apoptosis and adaptive immune responses.
Pattern and motion-related visual-evoked potentials in neuroborreliosis: follow-up study.
Safety of Striatal Infusion of siRNA in a Transgenic Huntington's Disease Mouse Model.
Changes in Serum Ceruloplasmin Levels Based on Immunomodulatory Treatments and Melatonin Supplementation in Multiple Sclerosis Patients.
The pathogenic relevance of αM-integrin in Guillain-Barré syndrome.
Clinical importance of F-waves as a prognostic factor in Guillain-Barré syndrome in children.
Engineering three dimensional micro nerve tissue using postnatal stem cells from human dental apical papilla.
Pediatric multiple sclerosis: Clinical features and outcome.
The Role of Imaging for Trigeminal Neuralgia: A Segmental Approach to High-Resolution MRI.
The curtain is drawn for both natalizumab and fingolimod (FTY720): a new era of multiple sclerosis therapy has arrived.
Long-term evolution of multiple sclerosis disability in the treatment era.

Pages